MRK (NYSE) - Merck & Company Inc
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US58933Y1055
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey. Web URL:
Classification
Market Cap in USD | 279,660m |
Sector | Healthcare |
Industry | Drug Manufacturers-General |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 1978-01-13 |
Ratings
Fundamental | 1.98 |
Dividend | 8.11 |
Performance 5y | 6.67 |
Rel. Performance vs Sector | -0.22 |
Analysts | 4.07 |
Fair Price Total Ret. | 101.03 |
Fair Price DCF | todo |
Technical
Growth TTM | 24.40% |
CAGR 5y | 12.19% |
CAGR / Mean Drawdown 5y | 1.75 |
Sharpe Ratio TTM | 0.96 |
Alpha vs SP500 TTM | 15.15 |
Beta vs SP500 5y weekly | 0.48 |
CAPM | 6.42% |
Average Daily Range 2m | 1.59% |
Reversal Oscillator | 9.92 |
Volatility GJR Garch 1y | 21.79% |
Price / SMA 50 | -2.92% |
Price / SMA 200 | -4.16% |
Current Volume | 5635.5k |
Average Volume 20d | 6191.4k |
Dividends
Yield TTM | 2.81% |
Yield on Cost 5y | 4.98% |
Dividends CAGR 5y | 8.09% |
Consistency of Dividends all time | 97.8% |